PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $20,917 | -66.5% | 3,294 | -47.5% | 0.00% | -100.0% |
| Q3 2021 | $62,509 | -59.3% | 6,276 | -45.9% | 0.00% | -50.0% |
| Q2 2021 | $153,518 | +17.1% | 11,595 | +54.7% | 0.00% | 0.0% |
| Q1 2021 | $131,048 | -31.6% | 7,497 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $191,698 | +209.5% | 7,497 | +58.7% | 0.00% | +200.0% |
| Q3 2020 | $61,932 | -51.8% | 4,724 | +0.4% | 0.00% | -50.0% |
| Q2 2020 | $128,560 | – | 4,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |